Passing the baton
By Rob Clancy, staff writer
Congratulations to Professor Ron Firestein, who was announced this week as Deputy Director of Hudson Institute of Medical Research.
Professor Firestein is a clinician scientist whose research focuses on identifying new targets and developing therapies for childhood cancers.
Ron joined Hudson Institute as the Head of the Centre for Cancer Research in 2015 and has since gone on to develop a major program at the Institute in children’s cancer. He is also co-leader and Head of the Victorian Paediatric Cancer Consortium (VPCC).
As well as continuing his research into other forms of cancer, Prof Firestein is a driving force behind the creation of the VPCC’s Childhood Cancer Model Atlas (CCMA) – a tissue bank which is the largest collection of high-risk paediatric solid tumour cell lines in the world.
Professor Hertzog continuing to lead
Professor Firestein takes over from Professor Paul Hertzog, who has contributed greatly to the formation and development of the Institute from when he was appointed Deputy Director at the time of the merger in 2014.
During his tenure as Deputy Director Paul has overseen the rapid growth of our inflammation expertise with our Director, Professor Elizabeth Hartland, to the point where we now house the largest group of inflammation researchers in Australia.
While he hands over the Deputy Director title, Prof Hertzog remains integral to the Hudson Institute’s strength in inflammation research, continuing to lead his research group and supporting our vision for a National Centre for Inflammation Research at Hudson Institute.
Contact us
Hudson Institute communications
t: + 61 3 8572 2761
e: communications@hudson.org.au
In this article
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”